by Manon Scorneaux | Feb 8, 2024 | Blog
Contract Development and Manufacturing Organizations (CDMOs) offer ready-to-go platforms to solve the viral vectors and vaccines manufacturing capacity bottleneck. These platforms can help biotherapeutics developers to reach clinical trials with a consistent,...
by Manon Scorneaux | Jan 19, 2024 | Blog
By Hanna P. Lesch, Chief Technology Officer, Emilie Gateau, Platform Development Manager, and Michele Marini, Scientific Marketing & Communication associate. The success of viral vector-based gene and cell therapy passes by rapid and smart scale-up technology,...
by Manon Scorneaux | Jan 19, 2024 | Blog
By Hanna P. Lesch, Chief Technology Officer, Emilie Gateau, Platform Development Manager, and Michele Marini, Scientific Marketing & Communication associate. The CGT Market Gene and cell therapy market is growing rapidly worldwide, and the viral vector...
